  See all
 |
Articles: Dermatologic Oncology |
Dexamethasone and hypoxia upregulate CXCR4 expression in myeloma cells
Leukemia and Lymphoma, 07/02/09
Prior Articles
Functional RET G691S polymorphism in cutaneous malignant melanoma
Oncogene, 07/01/09 Epigenetics in Human Melanoma
Cancer Control, 06/30/09
Free full text
Limiting the Morbidity of Inguinal Lymphadenectomy for Metastatic Melanoma
Cancer Control, 06/30/09
Free full text
Pediatric Melanoma: A Review
Cancer Control, 06/30/09
Free full text
Tumor Biomarkers in Melanoma
Cancer Control, 06/30/09
Free full text
Treatment combinations targeting apoptosis to improve immunotherapy of melanoma
Cancer Immunology, Immunotherapy, 06/30/09 Sentinel Lymph Node Biopsy for Melanoma: Indications and Rationale
Cancer Control, 06/30/09
Free full text
Exclusive Author Commentary Biochemotherapy in the treatment of metastatic melanoma in selected patients
Clinical and Translational Oncology, 06/30/09 Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma
Cancer, 06/29/09 Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant
European Journal of Cancer, 06/26/09 Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I–II AJCC skin melanoma: Outcome analysis from a single-institution prospectively collected database
European Journal of Cancer, 06/25/09 Impaired STAT Phosphorylation in T Cells from Melanoma Patients in Response to IL-2: Association with Clinical Stage
Clinical Cancer Research, 06/25/09 Chromosomal copy number changes supporting the classification of lentiginous junctional melanoma of the elderly as a subtype of melanoma
Modern Pathology, 06/24/09 Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma
Cancer, 06/23/09 Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: A phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma group
Journal of Clinical Oncology, 06/22/09 Role of fine-needle aspiration cytology in evaluation of cutaneous metastases
Diagnostic Cytopathology, 06/19/09 Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma
Journal of Clinical Oncology, 06/18/09 The number of lymph nodes involved with metastatic disease does not affect outcome in melanoma patients as long as all disease is confined to the sentinel lymph node
Annals of Surgical Oncology, 06/18/09
Free full text
Processing of MIA protein during melanoma cell migration
International Journal of Cancer, 06/16/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
